Summit Therapeutics Inc.
SMMTPharmaceutical Preparations · SIC 2834 · CIK 0001599298
Revenue FY2025
—
Net Income
$(1.08B)
EPS (Basic)
$-1.44
Net Margin
—
ROE
-163.9%
Total Equity
$0.66B
Shares Out
798M
Summit Therapeutics Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2019–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Baker Bros. Advisors
Baker Bros. Advisors
$477.7M
1.7%
(9.9%)
Adage Capital Management
Adage Capital Management
$29.0M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…